EUVIMEDEUVIMED entdecken
Crossref

Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo

Claudia Mugnaini iD, Antonella Brizzi iD, Marco Paolino, Enrico Scarselli, Riccardo Castelli iD, Modesto de Candia iD, Nicola Gambacorta, Orazio Nicolotti iD, Magdalena Kostrzewa, Poulami Kumar, Ali Mokhtar Mahmoud iD, Vittoria Borgonetti und 7 weitere

ACS Chemical Neuroscience · 06.03.2024 · 15 (5) · 955-971

DOI: 10.1021/acschemneuro.3c00656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 19.02.2024. Verfasst von Claudia Mugnaini und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy. Hauptthemen laut MEDLINE: Neuroprotective Agents, Neuroblastoma, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Ministero dell'Universit? e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsNeuroblastomaAlzheimer DiseaseCognitive DysfunctionHumansButyrylcholinesteraseAcetylcholinesteraseReceptors, CannabinoidCholinesterase InhibitorsMolecular Docking SimulationStructure-Activity Relationship

Stichwörter der Autor:innen

Alzheimer’s diseaseCB2R ligandscholinesterase inhibitorsdual-acting agentsmemory improvementneuroinflammationneuroprotection

Substanzen

ButyrylcholinesteraseAcetylcholinesteraseNeuroprotective AgentsReceptors, CannabinoidCholinesterase Inhibitors

Autor:innen und Institutionen

  • Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
  • Department of Food and Drug, University of Parma, 43124 Parma, Italy.
  • Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, 70125 Bari, Italy.
  • Institute of Biomolecular Chemistry, National Research Council of Italy, 80078 Pozzuoli, Naples ,Italy.
  • Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmacology and Toxicology, University of Florence, 50121 Florence, Italy.
  • Department of Experimental Medicine, Division of Pharmacology, University of Campania "L. Vanvitelli″, 80138 Naples, Italy.

ORCID-Profile: Claudia Mugnaini, Antonella Brizzi, Riccardo Castelli, Modesto de Candia, Orazio Nicolotti, Ali Mokhtar Mahmoud, Alessia Ligresti, Federico Corelli

Förderung

  • Ministero dell'Universit? e della Ricerca

Zitieren

APA

Mugnaini, C., Brizzi, A., Paolino, M., Scarselli, E., Castelli, R., de Candia, M., Gambacorta, N., Nicolotti, O., Kostrzewa, M., Kumar, P., Mahmoud, A. M., Borgonetti, V., Iannotta, M., Morace, A., Galeotti, N., Maione, S., Altomare, C. D., Ligresti, A., & Corelli, F. (2024). Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo. ACS Chemical Neuroscience, 15(5), 955-971. https://doi.org/10.1021/acschemneuro.3c00656

Vancouver

Mugnaini C, Brizzi A, Paolino M, Scarselli E, Castelli R, de Candia M, et al. Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo. ACS Chemical Neuroscience. 2024;15(5):955-971. doi:10.1021/acschemneuro.3c00656

BibTeX
@article{Mugnaini2024,
  author = {Mugnaini, Claudia and Brizzi, Antonella and Paolino, Marco and Scarselli, Enrico and Castelli, Riccardo and de Candia, Modesto and Gambacorta, Nicola and Nicolotti, Orazio and Kostrzewa, Magdalena and Kumar, Poulami and Mahmoud, Ali Mokhtar and Borgonetti, Vittoria and Iannotta, Monica and Morace, Andrea and Galeotti, Nicoletta and Maione, Sabatino and Altomare, Cosimo D and Ligresti, Alessia and Corelli, Federico},
  title = {Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo},
  journal = {ACS Chemical Neuroscience},
  year = {2024},
  volume = {15},
  number = {5},
  pages = {955--971},
  doi = {10.1021/acschemneuro.3c00656}
}
Kostenlos starten →